Therapeutic Targets Database
BIDD Pharmainformatics Databases
 
   
   

 

TTD Drug ID: DCL000450

Drug Information
NameAZD0328
SynonymsSpiro[1-azabicyclo[2.2.2]octane-8,8'-7-oxa-5-azabicyclo[4.3.0]nona-2,4,10-triene]; CID9794392; AR-R23465XX; AZD-0328
CompanyAstraZeneca
IndicationAlzheimer's disease; Schizophrenia
[ICD9: 295, 331.0   ICD10: F20, G30]
Terminated in Phase II    
Structure

Click to save drug structure in 3D MOL format

Click to save drug structure in 2D MOL format
InChI1S/C13H16N2O/c1-2-10-8-13(16-12(10)14-5-1)9-15-6-3-11(13)4-7-15/h
1-2,5,11H,3-4,6-9H2/t13-/m0/s1
InChIKeyOCKIPDMKGPYYJS-ZDUSSCGKSA-N
Canonical SMILESC1CN2CCC1C3(C2)CC4=C(O3)N=CC=C4    
Isomeric SMILESC1CN2CCC1[C@@]3(C2)CC4=C(O3)N=CC=C4
FormulaC13H16N2O
PubChem Compound IDCID 9794392.
PubChem Substance IDSID 14749001.
ClinicalTrials.govNCT00669903;
TargetNicotinic acetylcholine receptorAgonist[1][2]
Ref 1AstraZeneca. Product Development Pipeline. January 29 2009. To Reference
Ref 2AstraZeneca. Report of AstraZeneca. 31 January 2008. To Reference



 

Welcome to sign our Guestbook.

If you find any error in data or bug in web service, please kindly report it to Dr. Zhu.


Dr. Chen Yuzong
Deputy Director of Center for Computational Science and Engineering
Professor in Department of Pharmacy
National University of Singapore, Singapore


All rights reserved.

   
 
 
Computer-aided Drug Design
about BIDD |  databases |  software |  teaching |  research |  links

 

Department of Computational Science | National University of Singapore | Blk S17, 3 Science Drive 2, Singapore 117543